Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.14 | 30.46 |
| PEG Ratio (TTM) | -0.08 | -0.30 |
| P/S Ratio (TTM) | 0.27 | 3.55 |
| P/B Ratio (TTM) | 1.97 | 31.64 |
| P/FCF Ratio (TTM) | -5.21 | 24.48 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.42 |
| Price to 5YR AVG FCF Ratio | N/A | 24.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23.08% | 10.83% |
| ROE (TTM) | -133.58% | 118.83% |
| Net Profit Margin (TTM) | -11.35% | 13.03% |
| ROIC 5YR AVG | N/A | 26.38% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -10.68% | 48.21% | N/A |
| Revenue | -5.91% | 15.13% | N/A |
| Net Income | -10.60% | 0.88% | N/A |
| Cash Flow | -256.33% | 1.77% | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.07 | 0.91 |
| Quick Ratio (TTM) | 1.45 | 0.64 |
| D/E Ratio (TTM) | 1.22 | 3.86 |
| Interest Coverage (TTM) | -1.28 | 15.02 |
| Piotroski F-Score | 3 | 8 |
| Altman Z-Score | N/A | 5.30 |
| LTL to 5YR AVG FCF | N/A | 4.29 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.14% |